Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000198541 | SCV000252180 | uncertain significance | not specified | 2013-11-11 | criteria provided, single submitter | clinical testing | c.1724dupT: p.Cys576MetfsX2 (C576MfsX2) in exon 20 of the RARS2 gene (NM_020320.3). The normal sequence with the base that is duplicated in braces is: CCTG{T}ATGT. A variant of unknown significance has been identified in the RARS2 gene. The c.1724dupT sequence change has not been published as a mutation, nor has it been reported as a benign polymorphism to our knowledge. The c.1724dupT variant causes a frameshift starting with codon Cysteine 576, changes this amino acid to a Methionine residue and creates a premature Stop codon at position 2 of the new reading frame, denoted p.Cys576MetfsX2. This variant may cause loss of normal protein function through protein truncation; however, the introduction of the Stop codon occurs at the 3' end of the RARS2 gene. The effect of introducing a premature Stop codon so close to the end of the RARS2 gene is not known. Therefore, based on the currently available information, it is unclear whether c.1724dupT is a disease-causing mutation or a rare benign variant. The variant is found in MITONUC-MITOP panel(s). |
Natera, |
RCV001833152 | SCV002079889 | uncertain significance | Pontocerebellar hypoplasia type 6 | 2020-10-01 | no assertion criteria provided | clinical testing |